IKZF5 抗体 (N-Term)
Quick Overview for IKZF5 抗体 (N-Term) (ABIN927434)
抗原
See all IKZF5 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- N-Term
- 
                                            交叉反应
- 小鼠, 大鼠, 犬, 牛, 小鸡, 斑马鱼, Frog
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- ZNFN1 A5 antibody was raised in rabbit using the N terminal of ZNFN1 5 as the immunogen
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        WB: 0.2-1 µg/mL
 Optimal conditions should be determined by the investigator.
- 
                                            说明
- 
                        ZNFN1A5 Blocking Peptide, (ABIN5617263), is also available for use as a blocking control in assays to test for specificity of this ZNFN1A5 antibody 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 
                                            注意事项
- Avoid repeated freeze/thaw cycles.
- 
                                            储存条件
- 4 °C/-20 °C
- 
                                            储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
- 
                                            
- 
    - IKZF5 (IKAROS Family Zinc Finger 5 (Pegasus) (IKZF5))
- 
                                            别名
- ZNFN1A5
- 
                                            背景
- Members of the Ikaros family of transcription factors, which includes Pegasus, are expressed in lymphocytes and are implicated in the control of lymphoid development. Synonyms: Polyclonal ZNFN1A5 antibody, Anti-ZNFN1A5 antibody.
 抗原
- 
                    
 
                                     
                                     
                                    